Market Tracker

01/30 6:05pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

14.28
Data as of Jan 30
 -0.31 / -2.12%
Today’s Change
6.88
Today|||52-Week Range
16.80
+47.98%
Year-to-Date

Today’s Trading

Previous close14.59
Today’s open14.49
Day’s range14.25 - 15.00
Volume1,203,929
Average volume (3 months)1,762,840
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+18.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-0.05-0.64%
OPHTOphthotech Corp+0.42+0.75%
FMIFoundation Medicine ...-0.45-0.94%
OVASOvaScience Inc-2.24-4.90%
Data as of 4:00pm ET, 01/30/2015

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts